CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

The "U.S. Insulin Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

Aher holds an insulin pen next to his father, Lual, in their home in Ariath, Aweil North, South Sudan. 2025 © Isaac Buay ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

“Faster-acting drugs have a higher abuse potential,” said DiFeliceantonio. “They have a different impact on the brain. So if ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...